 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 10: October 2003
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; HYDROCODONE BITARTRATE
SOLUTION; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> AA VINTAGE PHARMS 500MG/15ML;7.5MG/15ML N40520 001 OCT 30, 2003 OCT NEWA
TABLET; ORAL
ANEXSIA
>D> AA MALLINCKRODT 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA
>A> AA 750MG;10MG N40468 001 OCT 31, 2002 OCT CTNA
ALBUTEROL SULFATE
TABLET, EXTENDED RELEASE; ORAL
>D> PROVENTIL
>D> BC SCHERING EQ 4MG BASE N19383 001 JUL 13, 1987 OCT DISC
>A> @ EQ 4MG BASE N19383 001 JUL 13, 1987 OCT DISC
ALPROSTADIL
INJECTABLE; INJECTION
CAVERJECT
>D> PHARMACIA AND UPJOHN 0.01MG/ML N20755 002 OCT 01, 1997 OCT DISC
>A> @ 0.01MG/ML N20755 002 OCT 01, 1997 OCT DISC
>D> AP 0.02MG/VIAL N20379 002 JUL 06, 1995 OCT CRLD
>A> AP + 0.02MG/VIAL N20379 002 JUL 06, 1995 OCT CRLD
>D> + 0.02MG/ML N20755 003 OCT 01, 1997 OCT DISC
>A> @ 0.02MG/ML N20755 003 OCT 01, 1997 OCT DISC
>A> AMLODIPINE MALEATE
>A> TABLET; ORAL
>A> AMVAZ
>A> DR REDDYS LABS INC 2.5MG N21435 001 OCT 31, 2003 OCT NEWA
>A> 5MG N21435 002 OCT 31, 2003 OCT NEWA
>A> + 10MG N21435 003 OCT 31, 2003 OCT NEWA
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE;
DEXTROAMPHETAMINE SULFATE
TABLET; ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
>A> AB MALLINCKRODT 1.25MG;1.25MG;1.25MG;1.25MG N40440 001 OCT 07, 2003 OCT NEWA
>A> AB 1.875MG;1.875MG;1.875MG;1.875MG N40440 002 OCT 07, 2003 OCT NEWA
>A> AB 2.5MG;2.5MG;2.5MG;2.5MG N40440 003 OCT 07, 2003 OCT NEWA
>A> AB 3.125MG;3.125MG;3.125MG;3.125MG N40440 004 OCT 07, 2003 OCT NEWA
>A> AB 3.75MG;3.75MG;3.75MG;3.75MG N40440 005 OCT 07, 2003 OCT NEWA
>A> AB 5MG;5MG;5MG;5MG N40440 006 OCT 07, 2003 OCT NEWA
>A> AB 7.5MG;7.5MG;7.5MG;7.5MG N40440 007 OCT 07, 2003 OCT NEWA
AMPICILLIN SODIUM
INJECTABLE; INJECTION
AMPICILLIN SODIUM
>D> AP APOTHECON EQ 125MG BASE/VIAL N62860 001 FEB 05, 1988 OCT WDGA
>A> @ EQ 125MG BASE/VIAL N62860 001 FEB 05, 1988 OCT WDGA
>D> AP EQ 250MG BASE/VIAL N62860 002 FEB 05, 1988 OCT WDGA
>A> @ EQ 250MG BASE/VIAL N62860 002 FEB 05, 1988 OCT WDGA
>D> AP EQ 500MG BASE/VIAL N62860 003 FEB 05, 1988 OCT WDGA
>A> @ EQ 500MG BASE/VIAL N62860 003 FEB 05, 1988 OCT WDGA
>D> AP EQ 1GM BASE/VIAL N62860 004 FEB 05, 1988 OCT WDGA
>A> @ EQ 1GM BASE/VIAL N62860 004 FEB 05, 1988 OCT WDGA
>D> AP EQ 2GM BASE/VIAL N62860 005 FEB 05, 1988 OCT WDGA
>A> @ EQ 2GM BASE/VIAL N62860 005 FEB 05, 1988 OCT WDGA
ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
ATROPINE AND DEMEROL
>D> + ABBOTT 0.4MG/ML;75MG/ML N87847 001 NOV 26, 1982 OCT WDGA
>A> @ 0.4MG/ML;75MG/ML N87847 001 NOV 26, 1982 OCT WDGA
>D> + 0.4MG/ML;100MG/ML N87848 001 NOV 26, 1982 OCT WDGA
>A> @ 0.4MG/ML;100MG/ML N87848 001 NOV 26, 1982 OCT WDGA
>D> + 0.4MG/ML;50MG/ML N87853 001 NOV 26, 1982 OCT WDGA
>A> @ 0.4MG/ML;50MG/ML N87853 001 NOV 26, 1982 OCT WDGA
BACLOFEN
>A> TABLET, ORALLY DISINTEGRATING; ORAL
>A> BACLOFEN
>A> SCHWARZ PHARMA 10MG N21589 001 OCT 30, 2003 OCT NEWA
>A> + 20MG N21589 002 OCT 30, 2003 OCT NEWA
BIVALIRUDIN
INJECTABLE; INTRAVENOUS
ANGIOMAX
>A> + MEDICINES CO 250MG/VIAL N20873 001 DEC 15, 2000 OCT CAHN
>D> + MEDS (TMC) 250MG/VIAL N20873 001 DEC 15, 2000 OCT CAHN
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
WELLBUTRIN SR
>D> GLAXOSMITHKLINE 150MG N20358 003 OCT 04, 1996 OCT CRLD
>A> + 150MG N20358 003 OCT 04, 1996 OCT CRLD
>D> + 200MG N20358 004 JUN 14, 2002 OCT CRLD
>A> 200MG N20358 004 JUN 14, 2002 OCT CRLD
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>D> AB CEPH INTL EQ 250MG BASE N62205 001 OCT CTNA
>A> AB EQ 250MG BASE N62205 001 OCT CTNA
>D> AB EQ 500MG BASE N62205 002 OCT CTNA
>A> AB EQ 500MG BASE N62205 002 OCT CTNA
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL
CEFADROXIL
>D> AB BARR EQ 500MG BASE N65015 001 JUN 22, 1999 OCT CAHN
>A> AB RANBAXY EQ 500MG BASE N65015 001 JUN 22, 1999 OCT CAHN
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>A> AP HIKMA FARMACEUTICA EQ 500MG BASE/VIAL N65047 001 SEP 18, 2001 OCT CAHN
>A> AP EQ 1GM BASE/VIAL N65047 002 SEP 18, 2001 OCT CAHN
>D> AP WESTWARD EQ 500MG BASE/VIAL N65047 001 SEP 18, 2001 OCT CAHN
>D> AP EQ 1GM BASE/VIAL N65047 002 SEP 18, 2001 OCT CAHN
CEFUROXIME AXETIL
TABLET; ORAL
CEFUROXIME AXETIL
>A> AB BIOCHEMIE US EQ 250MG BASE N65126 001 OCT 28, 2003 OCT NEWA
>A> AB EQ 500MG BASE N65126 002 OCT 28, 2003 OCT NEWA
CEPHALEXIN
CAPSULE; ORAL
CEPHALEXIN
>D> AB CEPH INTL EQ 250MG BASE N62118 001 OCT CTNA
>A> AB EQ 250MG BASE N62118 001 OCT CTNA
>D> AB EQ 500MG BASE N62118 002 OCT CTNA
>A> AB EQ 500MG BASE N62118 002 OCT CTNA
>D> AB TEVA EQ 250MG BASE N62821 001 FEB 05, 1988 OCT WDGA
>A> @ EQ 250MG BASE N62821 001 FEB 05, 1988 OCT WDGA
FOR SUSPENSION; ORAL
>D> + CEPH INTL EQ 100MG BASE/ML N62117 001 OCT CTNA
>A> + EQ 100MG BASE/ML N62117 001 OCT CTNA
>D> AB EQ 125MG BASE/5ML N62117 002 OCT CTNA
>A> AB EQ 125MG BASE/5ML N62117 002 OCT CTNA
>D> AB + EQ 250MG BASE/5ML N62117 003 OCT CTNA
>A> AB + EQ 250MG BASE/5ML N62117 003 OCT CTNA
CHLORAMBUCIL
TABLET; ORAL
LEUKERAN
>D> + GLAXOSMITHKLINE 2MG N10669 002 OCT CAHN
>A> + SMITHKLINE BEECHAM 2MG N10669 002 OCT CAHN
CHLORTHALIDONE
TABLET; ORAL
CHLORTHALIDONE
>D> AB MYLAN 50MG N86831 001 OCT CRLD
>A> AB + 50MG N86831 001 OCT CRLD
>D> HYGROTON
>D> AB AVENTIS PHARMS 25MG N12283 004 OCT DISC
>A> @ 25MG N12283 004 OCT DISC
>D> AB + 50MG N12283 003 OCT DISC
>A> @ 50MG N12283 003 OCT DISC
CILOSTAZOL
TABLET; ORAL
PLETAL
>D> OTSUKA 50MG N20863 001 JAN 15, 1999 OCT CRLD
>A> + 50MG N20863 001 JAN 15, 1999 OCT CRLD
CYCLOSPORINE
INJECTABLE; INJECTION
CYCLOSPORINE
>A> AP PHARMAFORCE 50MG/ML N65151 001 OCT 07, 2003 OCT NEWA
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL
DECLOMYCIN
>A> @ ESP PHARMA 75MG N50261 001 OCT CAHN
>A> 150MG N50261 002 OCT CAHN
>A> + 300MG N50261 003 OCT CAHN
>D> @ WYETH PHARMS INC 75MG N50261 001 OCT CAHN
>D> 150MG N50261 002 OCT CAHN
>D> + 300MG N50261 003 OCT CAHN
DEXCHLORPHENIRAMINE MALEATE
SYRUP; ORAL
MYLARAMINE
>D> AA MORTON GROVE 2MG/5ML N88251 001 MAR 23, 1984 OCT CRLD
>A> + 2MG/5ML N88251 001 MAR 23, 1984 OCT CRLD
>D> POLARAMINE
>D> AA SCHERING 2MG/5ML N86837 001 JUL 19, 1982 OCT DISC
>A> @ 2MG/5ML N86837 001 JUL 19, 1982 OCT DISC
TABLET; ORAL
DEXCHLORPHENIRAMINE MALEATE
>D> AA PLIVA 2MG N88682 001 JAN 17, 1986 OCT CRLD
>A> + 2MG N88682 001 JAN 17, 1986 OCT CRLD
>D> POLARAMINE
>D> AA + SCHERING 2MG N86835 001 OCT DISC
>A> @ 2MG N86835 001 OCT DISC
DIAZEPAM
GEL; RECTAL
DIASTAT
>D> + XCEL PHARMS 2.5MG/0.5ML N20648 001 JUL 29, 1997 OCT CRLD
>A> 2.5MG/0.5ML N20648 001 JUL 29, 1997 OCT CRLD
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDIZEM CD
>A> BC + AVENTIS PHARMS 360MG N20062 005 AUG 24, 1999 OCT NEWA
DOXYCYCLINE
CAPSULE; ORAL
DOXYCYCLINE
>A> + RANBAXY EQ 75MG BASE N65053 003 SEP 10, 2003 OCT NEWA
>A> EPINASTINE HYDROCHLORIDE
>A> SOLUTION/DROPS; OPHTHALMIC
>A> ELESTAT
>A> + ALLERGAN 0.05% N21565 001 OCT 16, 2003 OCT NEWA
EPINEPHRINE BITARTRATE; ETIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
DURANEST
>D> + ASTRAZENECA 0.005MG/ML;1% N17751 006 OCT WDGA
>A> @ 0.005MG/ML;1% N17751 006 OCT WDGA
ESTRADIOL HEMIHYDRATE
>A> EMULSION; TOPICAL
>A> ESTRASORB
>A> + NOVAVAX 0.25% N21371 001 OCT 09, 2003 OCT NEWA
FENOFIBRATE
CAPSULE; ORAL
>A> FENOFIBRATE (MICRONIZED)
>A> AB IMPAX LABS 67MG N75868 001 OCT 27, 2003 OCT NEWA
>A> AB 134MG N75868 002 OCT 27, 2003 OCT NEWA
>A> AB 200MG N75868 003 OCT 27, 2003 OCT NEWA
>D> TEVA 67MG N75753 001 SEP 03, 2002 OCT CFTG
>A> AB 67MG N75753 001 SEP 03, 2002 OCT CFTG
>D> 134MG N75753 002 APR 09, 2002 OCT CFTG
>A> AB 134MG N75753 002 APR 09, 2002 OCT CFTG
>D> + 200MG N75753 003 APR 09, 2002 OCT CFTG
>A> AB + 200MG N75753 003 APR 09, 2002 OCT CFTG
>A> FERRIC HEXACYANOFERRATE(II)
>A> CAPSULE; ORAL
>A> RADIOGARDASE (PRUSSIAN BLUE)
>A> + HEYDT 500MG N21626 001 OCT 02, 2003 OCT NEWA
FLURANDRENOLIDE
LOTION; TOPICAL
CORDRAN
>D> + OCLASSEN 0.05% N13790 001 OCT CAHN
>A> + WATSON LABS 0.05% N13790 001 OCT CAHN
>A> FOSAMPRENAVIR CALCIUM
>A> TABLET; ORAL
>A> LEXIVA
>A> + GLAXOSMITHKLINE EQ 700MG BASE N21548 001 OCT 20, 2003 OCT NEWA
GADOTERIDOL
INJECTABLE; INJECTION
>A> PROHANCE MULTIPACK
>A> + BRACCO 279.3MG/ML N21489 001 OCT 09, 2003 OCT NEWA
GLYBURIDE
TABLET; ORAL
GLYBURIDE (MICRONIZED)
>D> AB AVENTIS PHARMS 1.5MG N20055 001 APR 17, 1992 OCT DISC
>A> @ 1.5MG N20055 001 APR 17, 1992 OCT DISC
>D> AB 3MG N20055 002 APR 17, 1992 OCT DISC
>A> @ 3MG N20055 002 APR 17, 1992 OCT DISC
>D> AB 6MG N20055 003 MAR 08, 2000 OCT DISC
>A> @ 6MG N20055 003 MAR 08, 2000 OCT DISC
GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
SOLUTION/DROPS; OPHTHALMIC
NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN
>D> AT BAUSCH AND LOMB 0.025MG/ML;EQ 1.75MG BASE/ML;10,000
UNITS/ML N64047 001 JAN 31, 1996 OCT CRLD
>A> AT + 0.025MG/ML;EQ 1.75MG BASE/ML;10,000
UNITS/ML N64047 001 JAN 31, 1996 OCT CRLD
HEPARIN SODIUM
INJECTABLE; INJECTION
>D> SODIUM HEPARIN
>D> AP BAXTER HLTHCARE 1,000 UNITS/ML N17036 001 MAR 04, 1988 OCT DISC
>A> @ 1,000 UNITS/ML N17036 001 MAR 04, 1988 OCT DISC
HYDROCORTISONE; POLYMYXIN B SULFATE
SOLUTION/DROPS; OTIC
OTOBIOTIC
>D> + SCHERING 5MG/ML;EQ 10,000 UNITS BASE/ML N62302 001 OCT WDGA
>A> @ 5MG/ML;EQ 10,000 UNITS BASE/ML N62302 001 OCT WDGA
HYDROXYZINE PAMOATE
SUSPENSION; ORAL
VISTARIL
>D> PFIZER EQ 25MG HCL/5ML N11795 001 OCT CRLD
>A> + EQ 25MG HCL/5ML N11795 001 OCT CRLD
ISOSORBIDE DINITRATE
TABLET; ORAL
ISORDIL
>D> AB BIOVAIL 40MG N12093 001 JUL 29, 1988 OCT CRLD
>A> + 40MG N12093 001 JUL 29, 1988 OCT CRLD
SORBITRATE
>D> AB ASTRAZENECA 20MG N86405 002 AUG 21, 1990 OCT WDGA
>A> @ 20MG N86405 002 AUG 21, 1990 OCT WDGA
>D> AB 40MG N88125 001 AUG 21, 1990 OCT WDGA
>A> @ 40MG N88125 001 AUG 21, 1990 OCT WDGA
TABLET, CHEWABLE; ORAL
>D> + ASTRAZENECA 10MG N16776 003 APR 01, 1996 OCT WDGA
>A> @ 10MG N16776 003 APR 01, 1996 OCT WDGA
ISOSORBIDE MONONITRATE
TABLET, EXTENDED RELEASE; ORAL
IMDUR
>D> AB + SCHERING 30MG N20225 001 AUG 12, 1993 OCT CAHN
>D> AB + 60MG N20225 002 AUG 12, 1993 OCT CAHN
>D> AB + 120MG N20225 003 MAR 30, 1995 OCT CAHN
>A> AB + SCHERING PLOUGH 30MG N20225 001 AUG 12, 1993 OCT CAHN
>A> AB + 60MG N20225 002 AUG 12, 1993 OCT CAHN
>A> AB + 120MG N20225 003 MAR 30, 1995 OCT CAHN
KETOROLAC TROMETHAMINE
INJECTABLE; INJECTION
KETOROLAC TROMETHAMINE
>D> AP ABBOTT 15MG/ML N74801 001 JUN 05, 1997 OCT DISC
>A> @ 15MG/ML N74801 001 JUN 05, 1997 OCT DISC
>D> AP 30MG/ML N74801 002 JUN 05, 1997 OCT DISC
>A> @ 30MG/ML N74801 002 JUN 05, 1997 OCT DISC
>D> AP BEDFORD 30MG/ML N75228 001 APR 26, 1999 OCT CRLD
>A> AP + 30MG/ML N75228 001 APR 26, 1999 OCT CRLD
LABETALOL HYDROCHLORIDE
TABLET; ORAL
LABETALOL HCL
>D> AB APOTHECON 100MG N75223 001 NOV 20, 1998 OCT WDGA
>A> @ 100MG N75223 001 NOV 20, 1998 OCT WDGA
>D> AB 200MG N75223 002 NOV 20, 1998 OCT WDGA
>A> @ 200MG N75223 002 NOV 20, 1998 OCT WDGA
>D> AB 300MG N75223 003 NOV 20, 1998 OCT WDGA
>A> @ 300MG N75223 003 NOV 20, 1998 OCT WDGA
LEUCOVORIN CALCIUM
FOR SOLUTION; ORAL
LEUCOVORIN CALCIUM
>A> @ FAULDING EQ 60MG BASE/VIAL N08107 003 JAN 30, 1987 OCT CAHN
>D> @ XANODYNE PHARM EQ 60MG BASE/VIAL N08107 003 JAN 30, 1987 OCT CAHN
INJECTABLE; INJECTION
>A> @ FAULDING EQ 3MG BASE/ML N08107 001 OCT CAHN
>A> AP + EQ 50MG BASE/VIAL N08107 002 OCT CAHN
>A> AP + EQ 100MG BASE/VIAL N08107 004 MAY 23, 1988 OCT CAHN
>A> AP + EQ 350MG BASE/VIAL N08107 005 APR 05, 1989 OCT CAHN
>D> @ XANODYNE PHARM EQ 3MG BASE/ML N08107 001 OCT CAHN
>D> AP + EQ 50MG BASE/VIAL N08107 002 OCT CAHN
>D> AP + EQ 100MG BASE/VIAL N08107 004 MAY 23, 1988 OCT CAHN
>D> AP + EQ 350MG BASE/VIAL N08107 005 APR 05, 1989 OCT CAHN
LEVOFLOXACIN
INJECTABLE; INJECTION
LEVAQUIN
>D> + ORTHO MCNEIL PHARM EQ 500MG /20ML(25MG/ML) N20635 001 DEC 20, 1996 OCT CPOT
>A> + EQ 500MG /20ML(25MG/ML) N20635 001 DEC 20, 1996 OCT CPOT
>A> + EQ 750MG /30ML(25MG/ML) N20635 004 DEC 20, 1996 OCT NEWA
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> + ORTHO MCNEIL PHARM EQ 250MG /50ML(5MG/ML) N20635 002 DEC 20, 1996 OCT CPOT
>A> + EQ 250MG /50ML(5MG/ML) N20635 002 DEC 20, 1996 OCT CPOT
>D> + EQ 500MG 100ML/(5MG/ML) N20635 003 DEC 20, 1996 OCT CPOT
>A> + EQ 500MG 100ML/(5MG/ML) N20635 003 DEC 20, 1996 OCT CPOT
>A> + EQ 750MG /150ML(5MG/ML) N20635 005 DEC 20, 1996 OCT NEWA
>A> MEMANTINE HYDROCHLORIDE
>A> TABLET; ORAL
>A> NAMENDA
>A> FOREST LABS 5MG N21487 001 OCT 16, 2003 OCT NEWA
>A> + 10MG N21487 002 OCT 16, 2003 OCT NEWA
>A> @ 15MG N21487 003 OCT 16, 2003 OCT DISC
>A> @ 20MG N21487 004 OCT 16, 2003 OCT DISC
>D> 15MG N21487 003 OCT 16, 2003 OCT DISC
>D> 20MG N21487 004 OCT 16, 2003 OCT DISC
METHACHOLINE CHLORIDE
FOR SOLUTION; INHALATION
PROVOCHOLINE
>D> METHAPHARM 100MG/VIAL N19193 001 OCT 31, 1986 OCT CRLD
>A> + 100MG/VIAL N19193 001 OCT 31, 1986 OCT CRLD
METHOTREXATE SODIUM
INJECTABLE; INJECTION
METHOTREXATE LPF
>A> AP + FAULDING EQ 25MG BASE/ML N11719 007 MAR 31, 1982 OCT CAHN
>D> AP + WYETH PHARMS INC EQ 25MG BASE/ML N11719 007 MAR 31, 1982 OCT CAHN
METHOTREXATE SODIUM
>A> @ FAULDING EQ 2.5MG BASE/ML N11719 004 OCT CAHN
>A> + EQ 20MG BASE/VIAL N11719 001 OCT CAHN
>A> AP + EQ 25MG BASE/ML N11719 005 OCT CAHN
>A> @ EQ 50MG BASE/VIAL N11719 003 OCT CAHN
>A> @ EQ 100MG BASE/VIAL N11719 006 OCT CAHN
>D> @ WYETH PHARMS INC EQ 2.5MG BASE/ML N11719 004 OCT CAHN
>D> + EQ 20MG BASE/VIAL N11719 001 OCT CAHN
>D> AP + EQ 25MG BASE/ML N11719 005 OCT CAHN
>D> @ EQ 50MG BASE/VIAL N11719 003 OCT CAHN
>D> @ EQ 100MG BASE/VIAL N11719 006 OCT CAHN
METHOTREXATE SODIUM PRESERVATIVE FREE
>A> AP + FAULDING EQ 1GM BASE/VIAL N11719 009 APR 07, 1988 OCT CAHN
>D> AP + WYETH PHARMS INC EQ 1GM BASE/VIAL N11719 009 APR 07, 1988 OCT CAHN
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CONCERTA
>D> + MCNEIL CONS SPECLT 18MG N21121 001 AUG 01, 2000 OCT CRLD
>A> 18MG N21121 001 AUG 01, 2000 OCT CRLD
>D> + 27MG N21121 004 APR 01, 2002 OCT CRLD
>A> 27MG N21121 004 APR 01, 2002 OCT CRLD
>D> + 36MG N21121 002 AUG 01, 2000 OCT CRLD
>A> 36MG N21121 002 AUG 01, 2000 OCT CRLD
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
VECTRIN
>D> @ MEDICIS EQ 75MG BASE N63067 002 SEP 15, 1999 OCT CMFD
>A> AB EQ 75MG BASE N63067 002 SEP 15, 1999 OCT CMFD
>D> @ EQ 100MG BASE N63067 001 JUL 31, 1990 OCT CMFD
>A> AB EQ 100MG BASE N63067 001 JUL 31, 1990 OCT CMFD
NAFTIFINE HYDROCHLORIDE
CREAM; TOPICAL
NAFTIN
>D> @ ALLERGAN HERBERT 1% N19599 001 FEB 29, 1988 OCT CMFD
>A> 1% N19599 001 FEB 29, 1988 OCT CMFD
GEL; TOPICAL
>D> @ ALLERGAN HERBERT 1% N19356 001 JUN 18, 1990 OCT CMFD
>A> + 1% N19356 001 JUN 18, 1990 OCT CMFD
NAPROXEN SODIUM
TABLET; ORAL
NAPROXEN SODIUM
>D> AB AL HIKMA EQ 250MG BASE N74480 002 FEB 18, 1998 OCT CAHN
>D> AB EQ 500MG BASE N74480 001 MAY 14, 1996 OCT CAHN
>A> AB HIKMA EQ 250MG BASE N74480 002 FEB 18, 1998 OCT CAHN
>A> AB EQ 500MG BASE N74480 001 MAY 14, 1996 OCT CAHN
NOREPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
NOREPINEPHRINE BITARTRATE
>A> AP BEDFORD EQ 1MG BASE/ML N40462 001 OCT 31, 2003 OCT NEWA
OMEPRAZOLE
CAPSULE, DELAYED REL PELLETS; ORAL
OMEPRAZOLE
>A> AB TORPHARM 10MG N76048 001 OCT 06, 2003 OCT NEWA
>A> AB 20MG N76048 002 OCT 06, 2003 OCT NEWA
OXYCODONE HYDROCHLORIDE
TABLET; ORAL
ROXICODONE
>D> ELAN PHARMS 15MG N21011 001 AUG 31, 2000 OCT CRLD
>A> + 15MG N21011 001 AUG 31, 2000 OCT CRLD
>D> + 30MG N21011 002 AUG 31, 2000 OCT CRLD
>A> 30MG N21011 002 AUG 31, 2000 OCT CRLD
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HCL
>A> AA MUTUAL PHARM 30MG N40525 001 OCT 23, 2003 OCT NEWA
>A> AA 37.5MG N40527 001 OCT 23, 2003 OCT NEWA
TABLET; ORAL
>A> AA MUTUAL PHARM 37.5MG N40526 001 OCT 23, 2003 OCT NEWA
PIROXICAM
CAPSULE; ORAL
PIROXICAM
>D> AB SCS 10MG N74036 001 MAY 29, 1992 OCT WDGA
>A> @ 10MG N74036 001 MAY 29, 1992 OCT WDGA
>D> AB 20MG N74036 002 MAY 29, 1992 OCT WDGA
>A> @ 20MG N74036 002 MAY 29, 1992 OCT WDGA
PRAMIPEXOLE DIHYDROCHLORIDE
TABLET; ORAL
MIRAPEX
>D> PHARMACIA AND UPJOHN 0.25MG N20667 002 JUL 01, 1997 OCT CRLD
>A> + 0.25MG N20667 002 JUL 01, 1997 OCT CRLD
>D> + 1.5MG N20667 005 JUL 01, 1997 OCT CRLD
>A> 1.5MG N20667 005 JUL 01, 1997 OCT CRLD
PROCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
PROCAINE HCL
>D> AP AM PHARM PARTNERS 1% N80421 001 OCT DISC
>A> @ 1% N80421 001 OCT DISC
>D> AP 2% N80421 002 OCT DISC
>A> @ 2% N80421 002 OCT DISC
>D> AP ELKINS SINN 1% N83315 001 OCT DISC
>A> @ 1% N83315 001 OCT DISC
>D> AP 2% N83315 002 OCT DISC
>A> @ 2% N83315 002 OCT DISC
>D> AP STERIS 2% N80658 002 OCT DISC
>A> @ 2% N80658 002 OCT DISC
PYRIDOSTIGMINE BROMIDE
INJECTABLE; INJECTION
REGONOL
>D> @ SABEX 2002 5MG/ML N17398 001 OCT CMFD
>A> AP 5MG/ML N17398 001 OCT CMFD
TABLET; ORAL
PYRIDOSTIGMINE BROMIDE
>A> AB BARR 60MG N40512 001 OCT 08, 2003 OCT NEWA
RANITIDINE HYDROCHLORIDE
CAPSULE; ORAL
RANITIDINE HCL
>A> AB TEVA EQ 150MG BASE N75557 001 OCT 31, 2003 OCT NEWA
>A> AB EQ 300MG BASE N75557 002 OCT 31, 2003 OCT NEWA
RISPERIDONE
>A> INJECTABLE; INTRAMUSCULAR
>A> RISPERDAL CONSTA
>A> JOHNSON AND JOHNSON 25MG/VIAL N21346 001 OCT 29, 2003 OCT NEWA
>A> 37.5MG/VIAL N21346 002 OCT 29, 2003 OCT NEWA
>A> + 50MG/VIAL N21346 003 OCT 29, 2003 OCT NEWA
SILDENAFIL CITRATE
TABLET; ORAL
VIAGRA
>D> PFIZER 25MG N20895 001 MAR 27, 1998 OCT CAHN
>D> 50MG N20895 002 MAR 27, 1998 OCT CAHN
>D> + 100MG N20895 003 MAR 27, 1998 OCT CAHN
>A> PFIZER IRELAND 25MG N20895 001 MAR 27, 1998 OCT CAHN
>A> 50MG N20895 002 MAR 27, 1998 OCT CAHN
>A> + 100MG N20895 003 MAR 27, 1998 OCT CAHN
TESTOSTERONE ENANTHATE
INJECTABLE; INJECTION
DELATESTRYL
>D> @ BTG 200MG/ML N09165 001 OCT CAHN
>D> AO + 200MG/ML N09165 003 OCT CAHN
>A> @ SAVIENT PHARMS 200MG/ML N09165 001 OCT CAHN
>A> AO + 200MG/ML N09165 003 OCT CAHN
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
TETRACYCLINE HCL
>D> AB ROXANE 500MG N61214 002 OCT DISC
>A> @ 500MG N61214 002 OCT DISC
THALLOUS CHLORIDE, TL-201
INJECTABLE; INTRAVENOUS
THALLOUS CHLORIDE TL 201
>A> + BRISTOL MYERS SQUIBB 2mCi/ML N17806 002 OCT 09, 1998 OCT NEWA
TIROFIBAN HYDROCHLORIDE
INJECTABLE; INJECTION
AGGRASTAT
>A> + GUILFORD PHARMS EQ 0.05MG BASE/ML N20913 001 MAY 14, 1998 OCT CAHN
>A> + EQ 0.25MG BASE/ML N20912 001 MAY 14, 1998 OCT CAHN
>D> + MERCK EQ 0.05MG BASE/ML N20913 001 MAY 14, 1998 OCT CAHN
>D> + EQ 0.25MG BASE/ML N20912 001 MAY 14, 1998 OCT CAHN
TIZANIDINE HYDROCHLORIDE
TABLET; ORAL
TIZANIDINE HCL
>A> AB AMIDE PHARM EQ 2MG BASE N76281 001 OCT 20, 2003 OCT NEWA
>A> AB EQ 4MG BASE N76281 002 OCT 20, 2003 OCT NEWA
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
CREAM; VAGINAL
>D> GYNE-SULF
>D> AT G AND W LABS 3.7%;2.86%;3.42% N88607 001 JUN 09, 1986 OCT DISC
>A> @ 3.7%;2.86%;3.42% N88607 001 JUN 09, 1986 OCT DISC
TRIPLE SULFA
>D> AT ALPHARMA 3.7%;2.86%;3.42% N87864 001 SEP 01, 1982 OCT WDGA
>A> @ 3.7%;2.86%;3.42% N87864 001 SEP 01, 1982 OCT WDGA
>D> AT CLAY PARK 3.7%;2.86%;3.42% N87285 001 NOV 15, 1982 OCT DISC
>A> @ 3.7%;2.86%;3.42% N87285 001 NOV 15, 1982 OCT DISC
>D> TRYSUL
>D> AT SAVAGE LABS 3.7%;2.86%;3.42% N87887 001 JUL 23, 1982 OCT DISC
>A> @ 3.7%;2.86%;3.42% N87887 001 JUL 23, 1982 OCT DISC
VINCRISTINE SULFATE
INJECTABLE; INJECTION
VINCRISTINE SULFATE
>A> AP AM PHARM 1MG/ML N76401 001 OCT 28, 2003 OCT NEWA
>D> + AM PHARM PARTNERS 1MG/ML N76296 001 DEC 20, 2002 OCT CTEC
>A> AP + 1MG/ML N76296 001 DEC 20, 2002 OCT CTEC
WARFARIN SODIUM
TABLET; ORAL
>A> JANTOVEN
>A> AB USL PHARMA 1MG N40416 001 OCT 02, 2003 OCT NEWA
>A> AB 2MG N40416 002 OCT 02, 2003 OCT NEWA
>A> AB 2.5MG N40416 003 OCT 02, 2003 OCT NEWA
>A> AB 3MG N40416 004 OCT 02, 2003 OCT NEWA
>A> AB 4MG N40416 005 OCT 02, 2003 OCT NEWA
>A> AB 5MG N40416 006 OCT 02, 2003 OCT NEWA
>A> AB 6MG N40416 007 OCT 02, 2003 OCT NEWA
>A> AB 7.5MG N40416 008 OCT 02, 2003 OCT NEWA
>A> AB 10MG N40416 009 OCT 02, 2003 OCT NEWA
ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE
TABLET, CHEWABLE; ORAL
FOAMICON
>D> NOVARTIS 80MG;20MG N72687 001 JUN 28, 1989 OCT WDGA
>A> @ 80MG;20MG N72687 001 JUN 28, 1989 OCT WDGA
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
LORATADINE AND PSEUDOEPHEDRINE SULFATE
>D> ANDRX PHARMS 10MG;240MG N75706 001 FEB 21, 2003 OCT CTNA
>A> 10MG;240MG N75706 001 FEB 21, 2003 OCT CTNA
NICOTINE
FILM, EXTENDED RELEASE; TRANSDERMAL
PROSTEP
>A> + AVEVA 11MG/24HR N19983 003 DEC 23, 1998 OCT CAHN
>A> + 22MG/24HR N19983 004 DEC 23, 1998 OCT CAHN
>D> + ELAN PHARM 11MG/24HR N19983 003 DEC 23, 1998 OCT CAHN
>D> + 22MG/24HR N19983 004 DEC 23, 1998 OCT CAHN
 Back
to Top 
Index Page
Date updated: November 21, 2003 |
|
